| iX Biopharma Ltd. (42C.si) | |||
|---|---|---|---|
| 0.041 -0.001 (-2.38%) | |||
| Open: | 0.0410 | Prev Close: | 0.0420 |
| High: | 0.0410 | Low: | 0.0410 |
| Volume: | 137,000 | Market Cap: | 31.418M |
| Year High: | 0.1300 | Year Low: | 0.0370 |
| Stock Technical Analysis | |
|---|---|
| Overall |   |
| Targets | Six months: 0.117 One year: 0.136 |
| Supports | Support1: 0.088 Support2: 0.080 |
| Resistances | Resistance1: 0.100 Resistance2: 0.117 |
| Pivot Point | 0.089  |
| Moving Averages | MA(5): 0.093 MA(20): 0.089
MA(100): 0.097 MA(250): 0.125 |
| MACD | MACD(12,26): Signal(12,26,9): |
| Stochastic Oscillator | %K(14,3): 91.1 %D(3): 89.6 |
| RSI | RSI(14): 57.4 |
| 52-Week | High: 0.184 Low: 0.075 Change(%): -44.0 |
| Average Volume(K) | 3-Month: 6767 10-Days: 10425.000000 |
| Moving Averages analysis |
|---|
| Price has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term. |
| Bollinger Bands Analysis |
|---|
| 42C.SI has closed below upper band by 27.0%. Bollinger Bands are 24.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock News |
|---|
|
|
|
| Financials | |
|---|---|
| EPS | |
| EPS Est. Current Year | |
| EPS Est. Next Year | |
| EPS Est. Next Quarter | |
| Forward EPS | |
| Shares Out. (M) | |
| Shares Float (M) | |
| Book Value (p.s.) | |
| PEG Ratio | |
| Profit Margin | |
| Operating Margin | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) | |
| Qtrly Rev. Growth | |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | |
| Levered Free Cash Flow (M) | |
| Valuation | |
|---|---|
| P/E | |
| P/E Growth Ratio | |
| P/BV | |
| P/S | |
| P/CF | |